NITA advocates the 0.22 µm air-eliminating final filter for the routine use of I.V. therapy administration. Filter characteristics, filter functions and potential risks of nonfiltered infusions are discussed. Standards of care from organizations to institutions are reviewed, DRGs, preservation of veins, and professional liability factors are discussed, stressing cost-justification.